BET inhibitors down-regulate the expression of the essential lncRNA <i>SMILO</i> in multiple myeloma through regulation of the transcription factor FLI1
Not available.
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2024-09-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/11766 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850261722460323840 |
|---|---|
| author | Nahia Gómez-Echarte Edurne San José-Enériz Arantxa Carrasco-León Naroa Barrena Estibaliz Miranda Leire Garate Beatriz García-Torre Sandra Alonso-Moreno Naroa Gimenez-Camino Estibaliz Urizar-Compains Danel Olaverri-Mendizabal Paula Aguirre-Ruiz Beñat Ariceta Luis-Esteban Tamariz-Amador Paula Rodriguez-Otero Francisco J. Planes Laura Belver José Ignacio Martín-Subero Felipe Prosper Xabier Agirre |
| author_facet | Nahia Gómez-Echarte Edurne San José-Enériz Arantxa Carrasco-León Naroa Barrena Estibaliz Miranda Leire Garate Beatriz García-Torre Sandra Alonso-Moreno Naroa Gimenez-Camino Estibaliz Urizar-Compains Danel Olaverri-Mendizabal Paula Aguirre-Ruiz Beñat Ariceta Luis-Esteban Tamariz-Amador Paula Rodriguez-Otero Francisco J. Planes Laura Belver José Ignacio Martín-Subero Felipe Prosper Xabier Agirre |
| author_sort | Nahia Gómez-Echarte |
| collection | DOAJ |
| description |
Not available.
|
| format | Article |
| id | doaj-art-d9ad4eb37a8149279d2b82a9df1dfc5d |
| institution | OA Journals |
| issn | 0390-6078 1592-8721 |
| language | English |
| publishDate | 2024-09-01 |
| publisher | Ferrata Storti Foundation |
| record_format | Article |
| series | Haematologica |
| spelling | doaj-art-d9ad4eb37a8149279d2b82a9df1dfc5d2025-08-20T01:55:19ZengFerrata Storti FoundationHaematologica0390-60781592-87212024-09-01999110.3324/haematol.2024.285966BET inhibitors down-regulate the expression of the essential lncRNA <i>SMILO</i> in multiple myeloma through regulation of the transcription factor FLI1Nahia Gómez-Echarte0Edurne San José-Enériz1Arantxa Carrasco-León2Naroa Barrena3Estibaliz Miranda4Leire Garate5Beatriz García-Torre6Sandra Alonso-Moreno7Naroa Gimenez-Camino8Estibaliz Urizar-Compains9Danel Olaverri-Mendizabal10Paula Aguirre-Ruiz11Beñat Ariceta12Luis-Esteban Tamariz-Amador13Paula Rodriguez-Otero14Francisco J. Planes15Laura Belver16José Ignacio Martín-Subero17Felipe Prosper18Xabier Agirre19Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Navarra, Spain; Cancer Centre Clínica Universidad de Navarra (CCUN), Pamplona, NavarraCentro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Navarra, Spain; Cancer Centre Clínica Universidad de Navarra (CCUN), Pamplona, Navarra, Spain; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), MadridCentro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Navarra, Spain; Cancer Centre Clínica Universidad de Navarra (CCUN), Pamplona, Navarra, Spain; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), MadridUniversidad de Navarra, Tecnun Escuela de Ingeniería, San Sebastián, País VascoCentro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Navarra, Spain; Cancer Centre Clínica Universidad de Navarra (CCUN), Pamplona, Navarra, Spain; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), MadridCancer Centre Clínica Universidad de Navarra (CCUN), Pamplona, Navarra, Spain; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain; Servicio de Hematología y Terapia Celular, Clínica Universidad de Navarra (CUN), Pamplona, NavarraInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), BarcelonaJosep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain; Catalan Institute of Oncology (ICO), Cancer Therapeutic Resistance Program (ProCURE), Badalona, BarcelonaCentro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Navarra, Spain; Cancer Centre Clínica Universidad de Navarra (CCUN), Pamplona, NavarraCentro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Navarra, Spain; Cancer Centre Clínica Universidad de Navarra (CCUN), Pamplona, NavarraUniversidad de Navarra, Tecnun Escuela de Ingeniería, San Sebastián, País VascoCentro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Navarra, Spain; Cancer Centre Clínica Universidad de Navarra (CCUN), Pamplona, NavarraCentro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Navarra, Spain; Cancer Centre Clínica Universidad de Navarra (CCUN), Pamplona, NavarraCancer Centre Clínica Universidad de Navarra (CCUN), Pamplona, Navarra, Spain; Servicio de Hematología y Terapia Celular, Clínica Universidad de Navarra (CUN), Pamplona, NavarraCancer Centre Clínica Universidad de Navarra (CCUN), Pamplona, Navarra, Spain; Servicio de Hematología y Terapia Celular, Clínica Universidad de Navarra (CUN), Pamplona, NavarraUniversidad de Navarra, Tecnun Escuela de Ingeniería, San Sebastián, País VascoJosep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain; Catalan Institute of Oncology (ICO), Cancer Therapeutic Resistance Program (ProCURE), Badalona, BarcelonaInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), BarcelonaCentro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Navarra, Spain; Cancer Centre Clínica Universidad de Navarra (CCUN), Pamplona, Navarra, Spain; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain; Servicio de Hematología y Terapia Celular, Clínica Universidad de Navarra (CUN), Pamplona, NavarraCentro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Navarra, Spain; Cancer Centre Clínica Universidad de Navarra (CCUN), Pamplona, Navarra, Spain; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid Not available. https://haematologica.org/article/view/11766 |
| spellingShingle | Nahia Gómez-Echarte Edurne San José-Enériz Arantxa Carrasco-León Naroa Barrena Estibaliz Miranda Leire Garate Beatriz García-Torre Sandra Alonso-Moreno Naroa Gimenez-Camino Estibaliz Urizar-Compains Danel Olaverri-Mendizabal Paula Aguirre-Ruiz Beñat Ariceta Luis-Esteban Tamariz-Amador Paula Rodriguez-Otero Francisco J. Planes Laura Belver José Ignacio Martín-Subero Felipe Prosper Xabier Agirre BET inhibitors down-regulate the expression of the essential lncRNA <i>SMILO</i> in multiple myeloma through regulation of the transcription factor FLI1 Haematologica |
| title | BET inhibitors down-regulate the expression of the essential lncRNA <i>SMILO</i> in multiple myeloma through regulation of the transcription factor FLI1 |
| title_full | BET inhibitors down-regulate the expression of the essential lncRNA <i>SMILO</i> in multiple myeloma through regulation of the transcription factor FLI1 |
| title_fullStr | BET inhibitors down-regulate the expression of the essential lncRNA <i>SMILO</i> in multiple myeloma through regulation of the transcription factor FLI1 |
| title_full_unstemmed | BET inhibitors down-regulate the expression of the essential lncRNA <i>SMILO</i> in multiple myeloma through regulation of the transcription factor FLI1 |
| title_short | BET inhibitors down-regulate the expression of the essential lncRNA <i>SMILO</i> in multiple myeloma through regulation of the transcription factor FLI1 |
| title_sort | bet inhibitors down regulate the expression of the essential lncrna i smilo i in multiple myeloma through regulation of the transcription factor fli1 |
| url | https://haematologica.org/article/view/11766 |
| work_keys_str_mv | AT nahiagomezecharte betinhibitorsdownregulatetheexpressionoftheessentiallncrnaismiloiinmultiplemyelomathroughregulationofthetranscriptionfactorfli1 AT edurnesanjoseeneriz betinhibitorsdownregulatetheexpressionoftheessentiallncrnaismiloiinmultiplemyelomathroughregulationofthetranscriptionfactorfli1 AT arantxacarrascoleon betinhibitorsdownregulatetheexpressionoftheessentiallncrnaismiloiinmultiplemyelomathroughregulationofthetranscriptionfactorfli1 AT naroabarrena betinhibitorsdownregulatetheexpressionoftheessentiallncrnaismiloiinmultiplemyelomathroughregulationofthetranscriptionfactorfli1 AT estibalizmiranda betinhibitorsdownregulatetheexpressionoftheessentiallncrnaismiloiinmultiplemyelomathroughregulationofthetranscriptionfactorfli1 AT leiregarate betinhibitorsdownregulatetheexpressionoftheessentiallncrnaismiloiinmultiplemyelomathroughregulationofthetranscriptionfactorfli1 AT beatrizgarciatorre betinhibitorsdownregulatetheexpressionoftheessentiallncrnaismiloiinmultiplemyelomathroughregulationofthetranscriptionfactorfli1 AT sandraalonsomoreno betinhibitorsdownregulatetheexpressionoftheessentiallncrnaismiloiinmultiplemyelomathroughregulationofthetranscriptionfactorfli1 AT naroagimenezcamino betinhibitorsdownregulatetheexpressionoftheessentiallncrnaismiloiinmultiplemyelomathroughregulationofthetranscriptionfactorfli1 AT estibalizurizarcompains betinhibitorsdownregulatetheexpressionoftheessentiallncrnaismiloiinmultiplemyelomathroughregulationofthetranscriptionfactorfli1 AT danelolaverrimendizabal betinhibitorsdownregulatetheexpressionoftheessentiallncrnaismiloiinmultiplemyelomathroughregulationofthetranscriptionfactorfli1 AT paulaaguirreruiz betinhibitorsdownregulatetheexpressionoftheessentiallncrnaismiloiinmultiplemyelomathroughregulationofthetranscriptionfactorfli1 AT benatariceta betinhibitorsdownregulatetheexpressionoftheessentiallncrnaismiloiinmultiplemyelomathroughregulationofthetranscriptionfactorfli1 AT luisestebantamarizamador betinhibitorsdownregulatetheexpressionoftheessentiallncrnaismiloiinmultiplemyelomathroughregulationofthetranscriptionfactorfli1 AT paularodriguezotero betinhibitorsdownregulatetheexpressionoftheessentiallncrnaismiloiinmultiplemyelomathroughregulationofthetranscriptionfactorfli1 AT franciscojplanes betinhibitorsdownregulatetheexpressionoftheessentiallncrnaismiloiinmultiplemyelomathroughregulationofthetranscriptionfactorfli1 AT laurabelver betinhibitorsdownregulatetheexpressionoftheessentiallncrnaismiloiinmultiplemyelomathroughregulationofthetranscriptionfactorfli1 AT joseignaciomartinsubero betinhibitorsdownregulatetheexpressionoftheessentiallncrnaismiloiinmultiplemyelomathroughregulationofthetranscriptionfactorfli1 AT felipeprosper betinhibitorsdownregulatetheexpressionoftheessentiallncrnaismiloiinmultiplemyelomathroughregulationofthetranscriptionfactorfli1 AT xabieragirre betinhibitorsdownregulatetheexpressionoftheessentiallncrnaismiloiinmultiplemyelomathroughregulationofthetranscriptionfactorfli1 |